NKGNNKGen Biotech Inc. Common Stock

0.0050USD0.00%Mkt Cap: 7.84M $P/E:

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. Th…

Key Statistics

Company
Market Cap7.84M $
Enterprise Value38.85M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-23.55M $
Revenue/Share
Last Price0.0050 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-1.71
EV/Revenue
P/S
P/B-0.06
EPS (TTM)-1.33
EPS (Forward)
52W Range
0.00101% of range0.3300
52W High0.3300 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE
ROA-93.33%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-21.95M $
CapEx (TTM)48.00K $
FCF Margin
FCF Yield-267.32%
Net Debt38.19M $
Net Debt/EBITDA-1.68
Balance Sheet
Debt/Equity-0.34
Current Ratio0.05
Quick Ratio0.00
Book Value/Sh-0.9810 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.130.60M
Float67.59M
Insiders58.97%
Institutions2.11%
Short Interest
Short Ratio0.4d
Short % Float5.53%
Short % Out.3.35%
Shares Short1.51M
Short (prev mo.)561.27K
Technical
SMA 500.0445 (-88.8%)
SMA 2000.0582 (-91.4%)
Beta0.72
S&P 52W Chg18.16%
Avg Vol (30d)7.89K
Avg Vol (10d)490
Technical Indicators
RSI (14)14.1
MACD-0.0138
MACD Signal-0.0138
MACD Hist.-0.0001
BB Upper0.0731 USD
BB Middle0.0222 USD
BB Lower-0.0286 USD
BB Width456.92%
ATR (14)0.0042 USD
Vol Ratio (20d)0.00x